Michael G Kaplitt

Michael G Kaplitt, M.D., Ph.D., is a leading Professor of Neurological Surgery at Weill Cornell Medical College, with additional appointments in Neurology, Otolaryngology-Head and Neck Surgery, and Neuroscience. He serves as the David and Ursel Barnes Professor in Minimally Invasive Surgery, focusing on surgical treatments for movement disorders like Parkinson's disease and essential tremor, particularly pioneering MR-guided focused ultrasound techniques.

• Education:
  • Ph.D. in Molecular Neurobiology from The Rockefeller University (1993)
  • M.D. from Weill Cornell Medical College (1995)
  • B.A. in Molecular Biology and Russian Studies from Princeton University (1987)

His research spans gene therapy for neurodegenerative diseases, molecular neurobiology, and neurosurgical innovations. Notably, he conducted the first FDA-approved gene therapy trial for Parkinson's Disease and continues investigating AAV vectors and focused ultrasound applications.

Dr. Kaplitt has published over 40 papers and edited two books, including Gene Therapy of the Central Nervous System: From Bench to Bedside. His scientific awards include the Young Investigator Award from the American Society for Gene Therapy and Crain's 40 Under 40 recognition.

He collaborates with institutions like MeiraGTx, LLC and Graviton Bioscience Corporation, holding proprietary interests in gene therapy technologies. His clinical expertise includes deep brain stimulation, spinal cord stimulators, and trigeminal neuralgia treatment.